Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
Market Analysis and Insights: Global Novel Drug Delivery Systems in Cancer Therapy Market
The global Novel Drug Delivery Systems in Cancer Therapy market size is projected to reach US$ million by 2026, from US$ million in 2020, at a CAGR of % during 2021-2026.
Global Novel Drug Delivery Systems in Cancer Therapy Scope and Segment
The global Novel Drug Delivery Systems in Cancer Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Novel Drug Delivery Systems in Cancer Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
Nanoparticles
Liquid Embolics
Embolization Particles
By the application, this report covers the following segments
Hospitals & Clinic
Cancer Treatment Centers
Others
Competitive Landscape:
The Novel Drug Delivery Systems in Cancer Therapy key manufacturers in this market include:
Teva
Johnson & Johnson
Roche
Takeda
AbbVie
Samyang Biopharmaceuticals
Celgene
Spectrum Pharmaceuticals, Inc.
Gilead Sciences
Shire (Baxalta)
Merrimack
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
Market Analysis and Insights: Global Novel Drug Delivery Systems in Cancer Therapy Market
The global Novel Drug Delivery Systems in Cancer Therapy market size is projected to reach US$ million by 2026, from US$ million in 2020, at a CAGR of % during 2021-2026.
Global Novel Drug Delivery Systems in Cancer Therapy Scope and Segment
The global Novel Drug Delivery Systems in Cancer Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Novel Drug Delivery Systems in Cancer Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026.
By the type, the market is primarily split into
Nanoparticles
Liquid Embolics
Embolization Particles
By the application, this report covers the following segments
Hospitals & Clinic
Cancer Treatment Centers
Others
Competitive Landscape:
The Novel Drug Delivery Systems in Cancer Therapy key manufacturers in this market include:
Teva
Johnson & Johnson
Roche
Takeda
AbbVie
Samyang Biopharmaceuticals
Celgene
Spectrum Pharmaceuticals, Inc.
Gilead Sciences
Shire (Baxalta)
Merrimack
1 Market Overview of Novel Drug Delivery Systems in Cancer Therapy
1.1 Novel Drug Delivery Systems in Cancer Therapy Market Overview
1.1.1 Novel Drug Delivery Systems in Cancer Therapy Product Scope
1.1.2 Market Status and Outlook
1.2 Global Novel Drug Delivery Systems in Cancer Therapy Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Region (2015-2026)
1.4 Global Novel Drug Delivery Systems in Cancer Therapy Historic Market Size by Region (2015-2020)
1.5 Global Novel Drug Delivery Systems in Cancer Therapy Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2026)
1.6.1 North America Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2026)
1.6.2 Europe Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2026)
1.6.3 China Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2026)
1.6.5 Latin America Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2026)
2 Novel Drug Delivery Systems in Cancer Therapy Market Overview by Type
2.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Novel Drug Delivery Systems in Cancer Therapy Historic Market Size by Type (2015-2020)
2.3 Global Novel Drug Delivery Systems in Cancer Therapy Forecasted Market Size by Type (2021-2026)
2.4 Nanoparticles
2.5 Liquid Embolics
2.6 Embolization Particles
3 Novel Drug Delivery Systems in Cancer Therapy Market Overview by Application
3.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Novel Drug Delivery Systems in Cancer Therapy Historic Market Size by Application (2015-2020)
3.3 Global Novel Drug Delivery Systems in Cancer Therapy Forecasted Market Size by Application (2021-2026)
3.4 Hospitals & Clinic
3.5 Cancer Treatment Centers
3.6 Others
4 Global Novel Drug Delivery Systems in Cancer Therapy Competition Analysis by Players
4.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Novel Drug Delivery Systems in Cancer Therapy as of 2019)
4.3 Date of Key Manufacturers Enter into Novel Drug Delivery Systems in Cancer Therapy Market
4.4 Global Top Players Novel Drug Delivery Systems in Cancer Therapy Headquarters and Area Served
4.5 Key Players Novel Drug Delivery Systems in Cancer Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Novel Drug Delivery Systems in Cancer Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Teva
5.1.1 Teva Profile
5.1.2 Teva Main Business and Company’s Total Revenue
5.1.3 Teva Products, Services and Solutions
5.1.4 Teva Revenue (US$ Million) (2015-2020)
5.1.5 Teva Recent Development and Reaction to Covid-19
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Profile
5.2.2 Johnson & Johnson Main Business and Company’s Total Revenue
5.2.3 Johnson & Johnson Products, Services and Solutions
5.2.4 Johnson & Johnson Revenue (US$ Million) (2015-2020)
5.2.5 Johnson & Johnson Recent Development and Reaction to Covid-19
5.3 Roche
5.5.1 Roche Profile
5.3.2 Roche Main Business and Company’s Total Revenue
5.3.3 Roche Products, Services and Solutions
5.3.4 Roche Revenue (US$ Million) (2015-2020)
5.3.5 Takeda Recent Development and Reaction to Covid-19
5.4 Takeda
5.4.1 Takeda Profile
5.4.2 Takeda Main Business and Company’s Total Revenue
5.4.3 Takeda Products, Services and Solutions
5.4.4 Takeda Revenue (US$ Million) (2015-2020)
5.4.5 Takeda Recent Development and Reaction to Covid-19
5.5 AbbVie
5.5.1 AbbVie Profile
5.5.2 AbbVie Main Business and Company’s Total Revenue
5.5.3 AbbVie Products, Services and Solutions
5.5.4 AbbVie Revenue (US$ Million) (2015-2020)
5.5.5 AbbVie Recent Development and Reaction to Covid-19
5.6 Samyang Biopharmaceuticals
5.6.1 Samyang Biopharmaceuticals Profile
5.6.2 Samyang Biopharmaceuticals Main Business and Company’s Total Revenue
5.6.3 Samyang Biopharmaceuticals Products, Services and Solutions
5.6.4 Samyang Biopharmaceuticals Revenue (US$ Million) (2015-2020)
5.6.5 Samyang Biopharmaceuticals Recent Development and Reaction to Covid-19
5.7 Celgene
5.7.1 Celgene Profile
5.7.2 Celgene Main Business and Company’s Total Revenue
5.7.3 Celgene Products, Services and Solutions
5.7.4 Celgene Revenue (US$ Million) (2015-2020)
5.7.5 Celgene Recent Development and Reaction to Covid-19
5.8 Spectrum Pharmaceuticals, Inc.
5.8.1 Spectrum Pharmaceuticals, Inc. Profile
5.8.2 Spectrum Pharmaceuticals, Inc. Main Business and Company’s Total Revenue
5.8.3 Spectrum Pharmaceuticals, Inc. Products, Services and Solutions
5.8.4 Spectrum Pharmaceuticals, Inc. Revenue (US$ Million) (2015-2020)
5.8.5 Spectrum Pharmaceuticals, Inc. Recent Development and Reaction to Covid-19
5.9 Gilead Sciences
5.9.1 Gilead Sciences Profile
5.9.2 Gilead Sciences Main Business and Company’s Total Revenue
5.9.3 Gilead Sciences Products, Services and Solutions
5.9.4 Gilead Sciences Revenue (US$ Million) (2015-2020)
5.9.5 Gilead Sciences Recent Development and Reaction to Covid-19
5.10 Shire (Baxalta)
5.10.1 Shire (Baxalta) Profile
5.10.2 Shire (Baxalta) Main Business and Company’s Total Revenue
5.10.3 Shire (Baxalta) Products, Services and Solutions
5.10.4 Shire (Baxalta) Revenue (US$ Million) (2015-2020)
5.10.5 Shire (Baxalta) Recent Development and Reaction to Covid-19
5.11 Merrimack
5.11.1 Merrimack Profile
5.11.2 Merrimack Main Business and Company’s Total Revenue
5.11.3 Merrimack Products, Services and Solutions
5.11.4 Merrimack Revenue (US$ Million) (2015-2020)
5.11.5 Merrimack Recent Development and Reaction to Covid-19
6 North America Novel Drug Delivery Systems in Cancer Therapy by Players and by Application
6.1 North America Novel Drug Delivery Systems in Cancer Therapy Market Size and Market Share by Players (2015-2020)
6.2 North America Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)
7 Europe Novel Drug Delivery Systems in Cancer Therapy by Players and by Application
7.1 Europe Novel Drug Delivery Systems in Cancer Therapy Market Size and Market Share by Players (2015-2020)
7.2 Europe Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)
8 China Novel Drug Delivery Systems in Cancer Therapy by Players and by Application
8.1 China Novel Drug Delivery Systems in Cancer Therapy Market Size and Market Share by Players (2015-2020)
8.2 China Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)
9 Rest of Asia Pacific Novel Drug Delivery Systems in Cancer Therapy by Players and by Application
9.1 Rest of Asia Pacific Novel Drug Delivery Systems in Cancer Therapy Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)
10 Latin America Novel Drug Delivery Systems in Cancer Therapy by Players and by Application
10.1 Latin America Novel Drug Delivery Systems in Cancer Therapy Market Size and Market Share by Players (2015-2020)
10.2 Latin America Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)
11 Middle East & Africa Novel Drug Delivery Systems in Cancer Therapy by Players and by Application
11.1 Middle East & Africa Novel Drug Delivery Systems in Cancer Therapy Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)
12 Novel Drug Delivery Systems in Cancer Therapy Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
1.1 Novel Drug Delivery Systems in Cancer Therapy Market Overview
1.1.1 Novel Drug Delivery Systems in Cancer Therapy Product Scope
1.1.2 Market Status and Outlook
1.2 Global Novel Drug Delivery Systems in Cancer Therapy Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Region (2015-2026)
1.4 Global Novel Drug Delivery Systems in Cancer Therapy Historic Market Size by Region (2015-2020)
1.5 Global Novel Drug Delivery Systems in Cancer Therapy Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2026)
1.6.1 North America Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2026)
1.6.2 Europe Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2026)
1.6.3 China Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2026)
1.6.5 Latin America Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2026)
2 Novel Drug Delivery Systems in Cancer Therapy Market Overview by Type
2.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Novel Drug Delivery Systems in Cancer Therapy Historic Market Size by Type (2015-2020)
2.3 Global Novel Drug Delivery Systems in Cancer Therapy Forecasted Market Size by Type (2021-2026)
2.4 Nanoparticles
2.5 Liquid Embolics
2.6 Embolization Particles
3 Novel Drug Delivery Systems in Cancer Therapy Market Overview by Application
3.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Novel Drug Delivery Systems in Cancer Therapy Historic Market Size by Application (2015-2020)
3.3 Global Novel Drug Delivery Systems in Cancer Therapy Forecasted Market Size by Application (2021-2026)
3.4 Hospitals & Clinic
3.5 Cancer Treatment Centers
3.6 Others
4 Global Novel Drug Delivery Systems in Cancer Therapy Competition Analysis by Players
4.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Novel Drug Delivery Systems in Cancer Therapy as of 2019)
4.3 Date of Key Manufacturers Enter into Novel Drug Delivery Systems in Cancer Therapy Market
4.4 Global Top Players Novel Drug Delivery Systems in Cancer Therapy Headquarters and Area Served
4.5 Key Players Novel Drug Delivery Systems in Cancer Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Novel Drug Delivery Systems in Cancer Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Teva
5.1.1 Teva Profile
5.1.2 Teva Main Business and Company’s Total Revenue
5.1.3 Teva Products, Services and Solutions
5.1.4 Teva Revenue (US$ Million) (2015-2020)
5.1.5 Teva Recent Development and Reaction to Covid-19
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Profile
5.2.2 Johnson & Johnson Main Business and Company’s Total Revenue
5.2.3 Johnson & Johnson Products, Services and Solutions
5.2.4 Johnson & Johnson Revenue (US$ Million) (2015-2020)
5.2.5 Johnson & Johnson Recent Development and Reaction to Covid-19
5.3 Roche
5.5.1 Roche Profile
5.3.2 Roche Main Business and Company’s Total Revenue
5.3.3 Roche Products, Services and Solutions
5.3.4 Roche Revenue (US$ Million) (2015-2020)
5.3.5 Takeda Recent Development and Reaction to Covid-19
5.4 Takeda
5.4.1 Takeda Profile
5.4.2 Takeda Main Business and Company’s Total Revenue
5.4.3 Takeda Products, Services and Solutions
5.4.4 Takeda Revenue (US$ Million) (2015-2020)
5.4.5 Takeda Recent Development and Reaction to Covid-19
5.5 AbbVie
5.5.1 AbbVie Profile
5.5.2 AbbVie Main Business and Company’s Total Revenue
5.5.3 AbbVie Products, Services and Solutions
5.5.4 AbbVie Revenue (US$ Million) (2015-2020)
5.5.5 AbbVie Recent Development and Reaction to Covid-19
5.6 Samyang Biopharmaceuticals
5.6.1 Samyang Biopharmaceuticals Profile
5.6.2 Samyang Biopharmaceuticals Main Business and Company’s Total Revenue
5.6.3 Samyang Biopharmaceuticals Products, Services and Solutions
5.6.4 Samyang Biopharmaceuticals Revenue (US$ Million) (2015-2020)
5.6.5 Samyang Biopharmaceuticals Recent Development and Reaction to Covid-19
5.7 Celgene
5.7.1 Celgene Profile
5.7.2 Celgene Main Business and Company’s Total Revenue
5.7.3 Celgene Products, Services and Solutions
5.7.4 Celgene Revenue (US$ Million) (2015-2020)
5.7.5 Celgene Recent Development and Reaction to Covid-19
5.8 Spectrum Pharmaceuticals, Inc.
5.8.1 Spectrum Pharmaceuticals, Inc. Profile
5.8.2 Spectrum Pharmaceuticals, Inc. Main Business and Company’s Total Revenue
5.8.3 Spectrum Pharmaceuticals, Inc. Products, Services and Solutions
5.8.4 Spectrum Pharmaceuticals, Inc. Revenue (US$ Million) (2015-2020)
5.8.5 Spectrum Pharmaceuticals, Inc. Recent Development and Reaction to Covid-19
5.9 Gilead Sciences
5.9.1 Gilead Sciences Profile
5.9.2 Gilead Sciences Main Business and Company’s Total Revenue
5.9.3 Gilead Sciences Products, Services and Solutions
5.9.4 Gilead Sciences Revenue (US$ Million) (2015-2020)
5.9.5 Gilead Sciences Recent Development and Reaction to Covid-19
5.10 Shire (Baxalta)
5.10.1 Shire (Baxalta) Profile
5.10.2 Shire (Baxalta) Main Business and Company’s Total Revenue
5.10.3 Shire (Baxalta) Products, Services and Solutions
5.10.4 Shire (Baxalta) Revenue (US$ Million) (2015-2020)
5.10.5 Shire (Baxalta) Recent Development and Reaction to Covid-19
5.11 Merrimack
5.11.1 Merrimack Profile
5.11.2 Merrimack Main Business and Company’s Total Revenue
5.11.3 Merrimack Products, Services and Solutions
5.11.4 Merrimack Revenue (US$ Million) (2015-2020)
5.11.5 Merrimack Recent Development and Reaction to Covid-19
6 North America Novel Drug Delivery Systems in Cancer Therapy by Players and by Application
6.1 North America Novel Drug Delivery Systems in Cancer Therapy Market Size and Market Share by Players (2015-2020)
6.2 North America Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)
7 Europe Novel Drug Delivery Systems in Cancer Therapy by Players and by Application
7.1 Europe Novel Drug Delivery Systems in Cancer Therapy Market Size and Market Share by Players (2015-2020)
7.2 Europe Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)
8 China Novel Drug Delivery Systems in Cancer Therapy by Players and by Application
8.1 China Novel Drug Delivery Systems in Cancer Therapy Market Size and Market Share by Players (2015-2020)
8.2 China Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)
9 Rest of Asia Pacific Novel Drug Delivery Systems in Cancer Therapy by Players and by Application
9.1 Rest of Asia Pacific Novel Drug Delivery Systems in Cancer Therapy Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)
10 Latin America Novel Drug Delivery Systems in Cancer Therapy by Players and by Application
10.1 Latin America Novel Drug Delivery Systems in Cancer Therapy Market Size and Market Share by Players (2015-2020)
10.2 Latin America Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)
11 Middle East & Africa Novel Drug Delivery Systems in Cancer Therapy by Players and by Application
11.1 Middle East & Africa Novel Drug Delivery Systems in Cancer Therapy Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)
12 Novel Drug Delivery Systems in Cancer Therapy Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
